Systematic Financial Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-9,255
Closed -$349K 259
2020
Q2
$349K Sell
9,255
-1,535
-14% -$50.6K 0.02% 204
2020
Q1
$312K Sell
10,790
-590
-5% -$23.9K 0.02% 301
2019
Q4
$590K Buy
11,380
+1,495
+15% +$86.8K 0.02% 367
2019
Q3
$543K Sell
9,885
-13,275
-57% -$682K 0.02% 342
2019
Q2
$941K Sell
23,160
-12,450
-35% -$454K 0.04% 325
2019
Q1
$1.08M Sell
35,610
-1,875
-5% -$64.2K 0.04% 473
2018
Q4
$1.26M Buy
+37,485
New +$1.35M 0.04% 287
2016
Q4
Sell
-50,200
Closed -$2.4M 632
2016
Q3
$2.4M Sell
50,200
-21,559
-30% -$1.06M 0.03% 324
2016
Q2
$3.85M Buy
71,759
+34,640
+93% +$1.63M 0.05% 283
2016
Q1
$1.66M Sell
37,119
-4,105
-10% -$167K 0.02% 433
2015
Q4
$1.57M Sell
41,224
-18,640
-31% -$713K 0.02% 484
2015
Q3
$1.91M Sell
59,864
-16,110
-21% -$562K 0.02% 518
2015
Q2
$2.51M Buy
+75,974
New +$2.71M 0.02% 435
2014
Q3
Sell
-48,300
Closed -$2.24M 675
2014
Q2
$2.24M Sell
48,300
-592,827
-92% -$26.4M 0.02% 393
2014
Q1
$26.4M Buy
641,127
+509,187
+386% +$18.9M 0.18% 139
2013
Q4
$5.03M Buy
131,940
+68,770
+109% +$2.12M 0.04% 334
2013
Q3
$1.51M Buy
+63,170
New +$1.42M 0.01% 462

Other funds holding ANIK

Systematic Financial Management's ANIK Position: Q3 2020 in Review

Systematic Financial Management sold out of Anika Therapeutics (ANIK) in Q3 2020, closing a stake of 9,255 shares — an estimated $349K sold.

Systematic Financial Management first reported a position in ANIK in Q3 2013 and held it in 17 quarters. The position peaked at $26.4M in Q1 2014. 156 funds tracked by Wall St. Rank hold ANIK as of Q3 2020.

  • Systematic Financial Management reported no remaining Anika Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Systematic Financial Management sold 9,255 Anika Therapeutics shares in Q3 2020, an estimated $349K.
  • Systematic Financial Management first reported a position in Anika Therapeutics in Q3 2013 and held it in 17 quarters.
  • Systematic Financial Management's Anika Therapeutics position peaked at $26.4M in Q1 2014.
  • 156 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2020.

Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.